Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures

NCT: NCT04085887 · RECRUITING

NCT IDNCT04085887
StatusRECRUITING
Start Date2026-08
Completion2028-12
SponsorStanford University (OTHER)
First posted
Last updated

Brief Summary

The objective of the study is to assess safety of panitumumab-IRDye800 in pediatric patients undergoing brain surgery to remove suspected tumors.

Frequently Asked Questions

What is Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures?

Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures is a clinical trial registered under NCT04085887. Current status: RECRUITING.

What is the status of NCT04085887?

The current status of NCT04085887 (Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures) is: RECRUITING.

When did Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures start?

Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures started on 2026-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑